Many studies have revealed that FOXP1 is aberrantly expressed in several types of cancers and its expression frequently has a significant correlation with aggressive malignant phenotypes of tumors and poor prognosis in patients [11,12,16,17,18,19,21,26,27]. This evidence concerns the gene FOXP1 and cancer.